Stock VVOS VIVOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Vivos Therapeutics, Inc.

Equities

VVOS

US92859E2072

Delayed Nasdaq
Other stock markets
 10:43:47 2024-04-30 am EDT 		5-day change 1st Jan Change
2.5 USD -3.48% Intraday chart for Vivos Therapeutics, Inc. -5.78% -79.93%
Apr. 01 Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures MT
Apr. 01 Top Premarket Decliners MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ascendiant Capital Starts Vivos Therapeutics at Buy With $2.50 Price Target
MT
Roth Capital Lowers Price Target for Vivos Therapeutics to $8 From $9.75, Maintains Buy Rating
MT
VIVOS THERAPEUTICS : Roth Capital Adjusts Price Target on to $11 From $12, Maintains Buy Rating
MT
VIVOS THERAPEUTICS : Roth Capital Starts Vivos Therapeutics at Buy With $12 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VVOS Stock
  4. News Vivos Therapeutics, Inc.
  5. Analyst Reco.